<DOC>
	<DOC>NCT02786654</DOC>
	<brief_summary>The aim of the study is to investigate the association between the use of β blockers and mortality among hospital survivors of acute myocardial infarction without heart failure.</brief_summary>
	<brief_title>β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<criteria>acute myocardial infarction patients only aged 18 to 100 years other final diagnosis besides acute myocardial infarction died inhospital patients with missing mortality data aged &gt; 100 patients with previous acute myocardial infarction or angina patients who have received coronary interventions before patients with heart failure patients with β blocker prior use patients contraindicated for β blocker use patients with use of a loop diuretic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Acute myocardial infarction</keyword>
	<keyword>mortality</keyword>
	<keyword>evidence-based care</keyword>
	<keyword>Myocardial Ischaemia National Audit Project</keyword>
	<keyword>β blockers</keyword>
</DOC>